leadf
logo-loader
CSE:INNO

InnoCan Pharma

Receive alerts
Market:
CSE
Market Cap:
$31.56 m
Price
0.18 CAD
Change
0.00%
52 weeks high
0.40
52 weeks low
0.05

In brief

Innocan Pharma™ combines pharmaceutical experience with technological innovation to deliver the new generation of CBD integrated pharma and cosmetics products.

Snapshot

The Liposome Platform Technology has potential to become a licensing platform to large pharmaceutical companies either for CBD dosage or their own specific needs